🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21692Original Research

Deep learning in bone imaging diagnosis

ZHANG Xin¹,ZHANG Meishu¹,GE Miao¹,SUN Jianhao¹,LYU Longlong¹,GAO Peng¹

Weifang Hospital of Traditional Chinese Medicine, Weifang 261000, Shandong Province, China

Read Executive PreviewQuick FAQ
Deep learning in bone imaging diagnosis
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1905, Issue 33 • pp. 100-112Citation:ZHANG Xin et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Deep learning models significantly improve diagnostic efficiency and accuracy in bone imaging, including fracture, bone tumor, osteoporosis, osteoarthritis, synovitis, and spinal conditions. • Convolutional neural networks and derived models excel in classification, segmentation, and detection tasks, enabling automated feature extraction from skeletal images. • Current challenges include limited model generalization across different medical centers and imaging devices, and the need for large annotated datasets. • Future research should focus on enhancing model robustness, generalization, and interpretability to facilitate clinical adoption.
Sponsored Research Highlight

Abstract

BACKGROUND: Deep learning methods have made breakthrough progress in the field of bone imaging diagnosis. They have overcome the problems of easy misdiagnosis and low efficiency in traditional bone imaging diagnosis methods, and are conducive to the popularization of intelligent diagnosis methods in orthopedics. OBJECTIVE: To review the application, advantages and disadvantages of deep learning in the diagnosis of common bone diseases. METHODS: Literature published from January 2021 to June 2025 on deep learning-assisted skeletal image diagnosis was retrieved from CNKI, WanFang, PubMed, and Web of Science databases. Chinese and English search terms included “artificial intelligence, deep learning, machine learning, computer-aided diagnosis, skeletal imaging, fracture, bone tumor, osteoporosis, osteoarthritis, synovitis, spinal, cartilage, classification, detection, segmentation.” According to the inclusion criteria, 76 articles were finally included in this review. RESULTS AND CONCLUSION: Deep learning models have become powerful tools for bone imaging diagnosis and are gradually gaining recognition from clinicians, improving the efficiency of bone imaging diagnosis. Deep learning technology uses its image feature capture ability to help improve the clinical diagnosis of fractures, bone tumors, osteoporosis, osteoarthritis, synovitis, and spinal lesions, providing a reference for clinical decision-making. Although deep learning diagnostic applications have great potential, they are prone to insufficient model generalization and rely heavily on large amounts of annotated data, which reduces model credibility and hinders clinical translation. Future research should focus on improving the robustness and generalization of deep learning models. In summary, deep learning has certain reference value in clinical bone imaging diagnosis.

1. Introduction

Bone diseases are major public health problems affecting human health worldwide. According to statistics, about 520 million people suffer from osteoarthritis globally each year, osteoporosis causes about 9 million fragility fractures, and bone tumors have a high mortality rate. The structure and function of bones are the basis for maintaining human activities and are closely related to the body's mobility. Common clinical conditions, including fractures, bone tumors, osteoporosis, osteoarthritis, synovitis, and spinal lesions, seriously affect patients' normal life and impose a heavy burden on the healthcare system.

The diagnosis of bone diseases is currently based on medical imaging techniques such as X-ray, CT, and MRI, but the large amount of image data and the complexity of lesions can easily limit the diagnostic efficiency and accuracy of physicians. Therefore, it is of great significance to study efficient intelligent diagnostic methods for bone imaging.

With the rapid development of medical artificial intelligence, deep learning has been able to capture key features in complex bone images, thereby enabling complex lesion analysis and providing new ideas for the field of medical image analysis. More and more studies have proven that deep learning models based on convolutional neural networks are developing rapidly in the field of bone disease diagnosis, significantly improving the diagnostic efficiency and accuracy. However, systematic reviews on the application of deep learning in bone imaging diagnosis are relatively insufficient, lacking an overall analysis of multiple bone disease diagnostic applications. This article addresses the diagnostic problems of traditional bone imaging, summarizes the research progress of advanced deep learning applications, and provides a reference for clinical personnel.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
ZHANG Xin, ZHANG Meishu, GE Miao, SUN Jianhao, LYU Longlong, GAO Peng (2026). Deep learning in bone imaging diagnosis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21692
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the role of deep learning in bone imaging diagnosis?

Deep learning models, especially convolutional neural networks, automatically extract and analyze features from bone images, improving the detection, segmentation, and classification of various bone diseases such as fractures, tumors, osteoporosis, and osteoarthritis, thereby enhancing diagnostic efficiency and accuracy.

What are the main challenges of applying deep learning to bone imaging?

Key challenges include limited model generalization across different medical centers and imaging devices, heavy reliance on large annotated datasets, and the lack of interpretability, which hinder clinical acceptance and widespread adoption.

Which bone diseases can be diagnosed using deep learning?

Deep learning has been applied to diagnose fractures, bone tumors, osteoporosis, osteoarthritis, synovitis, and spinal lesions, among others, by analyzing X-ray, CT, and MRI images.

What future research directions are suggested for deep learning in bone imaging?

Future research should focus on improving model robustness and generalization, developing algorithms that can capture subtle features for complex lesions, and integrating explainable AI techniques to increase clinician trust and facilitate clinical translation.

How was this review conducted?

The review systematically searched CNKI, WanFang, PubMed, and Web of Science databases for literature published from January 2021 to June 2025, using specific keywords related to deep learning and bone imaging. After applying inclusion criteria, 76 articles were included for comprehensive analysis.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF